Genome-wide analyses identify distinct genetic architectures for depression (www.nature.com)

Recent genome-wide analyses have revealed significant differences in the genetic architectures of early-onset major depressive disorder (eoMDD) and late-onset major depressive disorder (loMDD). By leveraging extensive data from Nordic biobanks, researchers identified 12 distinct genomic loci for eoMDD and two for loMDD, indicating that these subtypes of depression possess partially unique genetic signatures. Notably, eoMDD is correlated with severe outcomes like suicide attempts, where a high polygenic risk score (PRS) predicted a considerably higher risk of suicide attempts within the first decade following diagnosis, demonstrating an absolute risk of 26% in the top risk decile. This study is significant for enhancing precision psychiatry, as it underscores the importance of stratifying depression by age at onset. The findings suggest that interventions could be tailored more effectively based on genetic predispositions associated with early or late onset. Moreover, the research highlighted how early-onset depression's genetic signals are particularly enriched in fetal brain development, pointing to critical developmental factors influencing its etiology. With the identification of genetic differences between eoMDD and loMDD, this work opens avenues for more targeted treatment strategies and improved understanding of the complex etiology underlying major depressive disorder.